Paul Kelly - Chief Operating Officer, Director at Relmada Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer, Director
Stock Symbol
RLMD on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Paul Kelly - trading volume in the past year for Relmada Therapeutics, Inc.

Holdings reported by Paul Kelly for Relmada Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 502K $1.11M $2.20 Nov 5, 2025 Direct
Stock Option (right to buy) 400K Jun 26, 2025 Direct Common Stock

Transactions reported by Paul Kelly for Relmada Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.